Imricor Medical Systems, Inc. announced it has entered into two new agreements with Siemens Healthcare GmbH that together provide Imricor the ability to deploy the Company's new 3D mapping system on the Siemens MRI platform. The objectives behind Imricor developing its own 3D mapping system, combined with the Siemens agreements announced here, are to commercialise a 3D mapping system for the Siemens platform sooner than previously possible and to provide Siemens iCMR sites an opportunity to participate in Imricor's planned ventricular tachycardia ablation (VT) clinical trial. The first agreement is an Access-i License Agreement which provides Imricor the ability to interface Imricor's new 3D mapping system to Siemens MRI scanners via the Access-i software interface available on newer Siemens scanners, including the Aera, Altea, and Sola systems. Access-i is a CE mark certified software product available from Siemens.

The second agreement is a Local Coil Agreement which allows Imricor catheters to be recognised across newer Siemens MRI scanners, including the Aera, Altea, and Sola systems. Both agreements have an initial term ending 31 December 2026 and shall be automatically extended by periods of 12 months thereafter, unless terminated by either party.